PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AUR vs. CLOV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


AURCLOV
YTD Return23.11%223.50%
1Y Return157.42%201.96%
3Y Return (Ann)-18.11%-25.93%
Sharpe Ratio1.692.42
Sortino Ratio2.393.21
Omega Ratio1.291.38
Calmar Ratio1.712.11
Martin Ratio4.8512.53
Ulcer Index30.95%16.36%
Daily Std Dev88.66%84.61%
Max Drawdown-93.34%-97.19%
Current Drawdown-68.56%-86.09%

Fundamentals


AURCLOV
Market Cap$9.28B$1.63B
EPS-$0.47-$0.19
Total Revenue (TTM)$0.00$1.54B
Gross Profit (TTM)-$48.00M$522.63M
EBITDA (TTM)-$741.00M-$68.65M

Correlation

-0.50.00.51.00.4

The correlation between AUR and CLOV is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

AUR vs. CLOV - Performance Comparison

In the year-to-date period, AUR achieves a 23.11% return, which is significantly lower than CLOV's 223.50% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%JuneJulyAugustSeptemberOctoberNovember
96.35%
246.24%
AUR
CLOV

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AUR vs. CLOV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Aurora Innovation, Inc. (AUR) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AUR
Sharpe ratio
The chart of Sharpe ratio for AUR, currently valued at 1.69, compared to the broader market-4.00-2.000.002.004.001.69
Sortino ratio
The chart of Sortino ratio for AUR, currently valued at 2.39, compared to the broader market-4.00-2.000.002.004.006.002.39
Omega ratio
The chart of Omega ratio for AUR, currently valued at 1.29, compared to the broader market0.501.001.502.001.29
Calmar ratio
The chart of Calmar ratio for AUR, currently valued at 1.71, compared to the broader market0.002.004.006.001.71
Martin ratio
The chart of Martin ratio for AUR, currently valued at 4.85, compared to the broader market0.0010.0020.0030.004.85
CLOV
Sharpe ratio
The chart of Sharpe ratio for CLOV, currently valued at 2.42, compared to the broader market-4.00-2.000.002.004.002.42
Sortino ratio
The chart of Sortino ratio for CLOV, currently valued at 3.21, compared to the broader market-4.00-2.000.002.004.006.003.21
Omega ratio
The chart of Omega ratio for CLOV, currently valued at 1.38, compared to the broader market0.501.001.502.001.38
Calmar ratio
The chart of Calmar ratio for CLOV, currently valued at 2.11, compared to the broader market0.002.004.006.002.11
Martin ratio
The chart of Martin ratio for CLOV, currently valued at 12.53, compared to the broader market0.0010.0020.0030.0012.53

AUR vs. CLOV - Sharpe Ratio Comparison

The current AUR Sharpe Ratio is 1.69, which is lower than the CLOV Sharpe Ratio of 2.42. The chart below compares the historical Sharpe Ratios of AUR and CLOV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
1.69
2.42
AUR
CLOV

Dividends

AUR vs. CLOV - Dividend Comparison

Neither AUR nor CLOV has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AUR vs. CLOV - Drawdown Comparison

The maximum AUR drawdown since its inception was -93.34%, roughly equal to the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for AUR and CLOV. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%JuneJulyAugustSeptemberOctoberNovember
-68.56%
-86.09%
AUR
CLOV

Volatility

AUR vs. CLOV - Volatility Comparison

Aurora Innovation, Inc. (AUR) has a higher volatility of 32.99% compared to Clover Health Investments, Corp. (CLOV) at 20.62%. This indicates that AUR's price experiences larger fluctuations and is considered to be riskier than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%40.00%JuneJulyAugustSeptemberOctoberNovember
32.99%
20.62%
AUR
CLOV

Financials

AUR vs. CLOV - Financials Comparison

This section allows you to compare key financial metrics between Aurora Innovation, Inc. and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items